AtheroNova, Inc. (OTCBB: AHRO)

AtheroNova (OTCBB: AHRO) is an early stage biotech company focused on discovery, research, development and licensing of novel compounds to reduce or regress atherosclerotic plaque deposits.  The Company's focus on compounds to reduce or eliminate atherosclerotic plaque deposits addresses the most lucrative segments of the multi-billion dollar prescription drug market: cardiovascular disease and stroke prevention.  www.AtheroNova.com

C.E.O. Thomas W. Gardner on atherosclerosis.

C.E.O. Thomas W. Gardner: What is the market size for atherosclerosis?

"Nature's detergent" at Atheronova, Inc. ($AHRO)

Thomas W. Gardner on Maxwell Biotech Group

The Founding of and the Potential for AtheroNova

AHRO @ Wikinvest

Flash Player 9 or higher is required to view the chart
Click here to download Flash Player now

View the full AHRO chart at Wikinvest

PER Equity Initiation Report on AHRO

AtheroNova Investor Presentation

Effect of Bile Salts on Lipid Fat - AtheroNova

AHRO @ Yahoo Finance